Avior Wealth Management LLC Cuts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avior Wealth Management LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,769 shares of the medical equipment provider’s stock after selling 126 shares during the quarter. Avior Wealth Management LLC’s holdings in Intuitive Surgical were worth $869,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in ISRG. West Family Investments Inc. raised its position in Intuitive Surgical by 32.4% in the third quarter. West Family Investments Inc. now owns 968 shares of the medical equipment provider’s stock valued at $476,000 after purchasing an additional 237 shares during the period. Parnassus Investments LLC raised its position in Intuitive Surgical by 36.8% in the third quarter. Parnassus Investments LLC now owns 2,133 shares of the medical equipment provider’s stock valued at $1,048,000 after purchasing an additional 574 shares during the period. B. Metzler seel. Sohn & Co. Holding AG purchased a new position in Intuitive Surgical in the third quarter valued at about $9,977,000. Banque Cantonale Vaudoise raised its position in Intuitive Surgical by 6.1% in the third quarter. Banque Cantonale Vaudoise now owns 8,332 shares of the medical equipment provider’s stock valued at $4,094,000 after purchasing an additional 480 shares during the period. Finally, SouthState Corp raised its position in Intuitive Surgical by 1.3% in the third quarter. SouthState Corp now owns 37,280 shares of the medical equipment provider’s stock valued at $18,315,000 after purchasing an additional 488 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 91,178 shares of company stock valued at $45,897,071 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $541.82 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $544.38. The stock has a market cap of $192.98 billion, a price-to-earnings ratio of 87.11, a PEG ratio of 5.19 and a beta of 1.39. The stock’s 50 day moving average price is $502.44 and its 200 day moving average price is $461.26.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. Raymond James lifted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.